CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 89 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $5,841,000 | -4.3% | 49,330 | -4.5% | 0.00% | -20.0% |
Q4 2020 | $6,102,000 | +3.2% | 51,664 | -2.9% | 0.01% | 0.0% |
Q3 2020 | $5,912,000 | +10.3% | 53,192 | +1.4% | 0.01% | 0.0% |
Q2 2020 | $5,360,000 | -18.3% | 52,458 | -13.7% | 0.01% | -37.5% |
Q1 2020 | $6,558,000 | -6.1% | 60,759 | +1.2% | 0.01% | +33.3% |
Q4 2019 | $6,985,000 | +19.0% | 60,023 | +17.0% | 0.01% | 0.0% |
Q3 2019 | $5,871,000 | +97.2% | 51,288 | +64.2% | 0.01% | +50.0% |
Q2 2019 | $2,977,000 | +8.8% | 31,241 | +4.2% | 0.00% | +33.3% |
Q1 2019 | $2,735,000 | +17.7% | 29,972 | -2.1% | 0.00% | 0.0% |
Q4 2018 | $2,323,000 | -14.4% | 30,607 | -9.7% | 0.00% | 0.0% |
Q3 2018 | $2,713,000 | -23.4% | 33,907 | -5.0% | 0.00% | -40.0% |
Q2 2018 | $3,544,000 | +8.1% | 35,682 | -11.8% | 0.01% | 0.0% |
Q1 2018 | $3,278,000 | -15.0% | 40,468 | -17.4% | 0.01% | 0.0% |
Q4 2017 | $3,857,000 | -6.6% | 48,964 | +9.4% | 0.01% | -16.7% |
Q3 2017 | $4,130,000 | – | 44,757 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |